Pharmaceutical Wholesaler Distributor

The state of Texas, specifically the Health and Human Services Commission (HHSC), is seeking a Pharmaceutical Wholesaler Distributor through a competitive Request for Proposal (RFP) process. The procurement, identified by solicitation number HHS0015752, aims to establish a comprehensive pharmaceutical distribution contract for state agencies. The primary objective is to secure a vendor capable of providing efficient, reliable, and cost-effective pharmaceutical distribution services across Texas. Potential respondents must demonstrate extensive experience in large-scale pharmaceutical wholesale distribution, including robust inventory management, precise delivery systems, and compliance with state and federal pharmaceutical regulations. The RFP requires detailed submissions outlining operational capabilities, distribution networks, technology infrastructure, and quality assurance protocols. Proposals are due by September 17, 2025, with the solicitation originally posted on August 5, 2025. Interested vendors should carefully review all attached documentation, particularly the exhibits contained in the ESBD_443343_1754421535384_Exhibits HHS0015752.zip file, to ensure full understanding of submission requirements and evaluation criteria.

While specific set-aside designations are not explicitly detailed in the available documentation, Texas state procurement typically encourages participation from Historically Underutilized Businesses (HUBs) and small/disadvantaged enterprises. The pharmaceutical distribution contract likely represents a significant opportunity with potential multi-year award value, though precise budget ranges are not specified in the provided materials. Respondents can anticipate a comprehensive evaluation process that will assess technical capabilities, distribution infrastructure, pricing models, and demonstrated experience in large-scale pharmaceutical logistics. The contract will potentially integrate with existing state healthcare distribution systems and technology platforms, requiring vendors to demonstrate technical compatibility and seamless operational integration. Prospective bidders should be prepared to provide extensive documentation regarding their distribution capabilities, compliance certifications, and ability to meet the state's pharmaceutical procurement and distribution requirements.